The Food and Drug Administration (FDA), part of the Department of Health and Human Services (HHS), obligated a total of $38,889,552.06 to Deloitte & Touche LLP under a blanket purchase agreement (BPA) call for business intelligence and publishing support to FDA's Center for Drug Evaluation and Research (CDER). The call (contract number 75F40120F19002) was signed May 13, 2020, and its period of performance ran through June 9, 2024, according to federal award data.

The work is classified under NAICS code 541990, All Other Professional, Scientific, and Technical Services, and was performed in Silver Spring, Montgomery County, Maryland — home to CDER's White Oak campus. The call was issued under an existing HHS-wide BPA vehicle (idv number HHSF223201700001B).

For GovCon practitioners, the closed-out call is a data point on the scale of professional-services spending FDA centers route through standing BPA vehicles for business intelligence and publishing support rather than stand-alone procurements. Deloitte & Touche LLP is classified in federal award data as a corporate entity that is not designated a small business.

Source: USAspending.gov